Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H17BrN2O2 |
Molecular Weight | 325.201 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
BrC1=CC=C(OC(=O)N2CCN3CCC2CC3)C=C1
InChI
InChIKey=RXLOZRCLQMJJLC-UHFFFAOYSA-N
InChI=1S/C14H17BrN2O2/c15-11-1-3-13(4-2-11)19-14(18)17-10-9-16-7-5-12(17)6-8-16/h1-4,12H,5-10H2
Molecular Formula | C14H17BrN2O2 |
Molecular Weight | 325.201 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P36544 Gene ID: 1139|||89832 Gene Symbol: CHRNA7 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17019409 |
14.0 nM [Ki] | ||
Target ID: P36544 Gene ID: 1139|||89832 Gene Symbol: CHRNA7 Target Organism: Homo sapiens (Human) |
14.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Alpha7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice. | 2009 Jan 5 |
|
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease. | 2010 May 27 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 07:56:43 GMT 2023
by
admin
on
Sat Dec 16 07:56:43 GMT 2023
|
Record UNII |
QF4P1U1666
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9797360
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY | |||
|
300000041443
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY | |||
|
SSR-180,711
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY | |||
|
298198-52-4
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY | |||
|
QF4P1U1666
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY | |||
|
DTXSID2047359
Created by
admin on Sat Dec 16 07:56:43 GMT 2023 , Edited by admin on Sat Dec 16 07:56:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT |
|